The Paul, Weiss Litigation Department is led by a team of the country’s most accomplished trial lawyers. Our litigators in New York and Washington, D.C. handle the most complex and demanding lawsuits, class actions, government investigations, criminal prosecutions and restructurings. Our clients include Fortune 50 corporations and other prominent companies in the financial services, investment, medical device, pharmaceutical, sports, technology, energy, media and insurance industries. Every day, we are called on by chief executives, board chairs, general counsel, investors and entrepreneurs for our unmatched trial skills, sophisticated business judgment and renowned strategic advice.

Firm News

Paul, Weiss Adds Kannon Shanmugam, Renowned Supreme Court and Appellate Lawyer

Kannon Shanmugam, a renowned Supreme Court and appellate lawyer, has joined Paul, Weiss as a partner in the Litigation Department and will chair the Supreme Court and Appellate Litigation Group.

» more

Client News

In Landmark Victory, Delaware Supreme Court Affirms that Fresenius Can Terminate Akorn Deal

Paul, Weiss secured a landmark victory for German healthcare group Fresenius SE & Co. when the Delaware Supreme Court affirmed that Fresenius was justified in canceling its $4.8 billion agreement to acquire Illinois-based Akorn, Inc.

» more

Client News

Paul, Weiss Wins $1 Billion Judgment for Citi in Parmalat Litigation

Eleven years after Paul, Weiss litigation partners Ted Wells and Jack Baughman won a trial verdict for client Citigroup Inc. in New Jersey, Italy’s Supreme Court ruled on April 16 that the 2008 court award against failed Italian dairy giant Parmalat SpA is final and enforceable in Italy.

» more

Awards & Recognition

The American Lawyer Names Andrew Gordon “Litigator of the Week”

Litigation partner Andrew Gordon was named “Litigator of the Week” by The American Lawyer, following a summary judgment victory by Andrew and litigation partners Greg Laufer and Julia Wood on behalf of hedge fund administrator Citco Group.

» more

Client News

Cigna Secures DOJ Clearance of $67 Billion Express Scripts Acquisition

Cigna announced that the Antitrust Division of the DOJ cleared Cigna’s $67 billion acquisition of pharmacy benefits manager Express Scripts Holding.

» more

Client News

Merck Prevails in Vytorin Securities Litigation

Paul, Weiss secured the final dismissal of remaining claims brought by investors in a decade-long securities law dispute against our clients Merck & Co., Inc. and Schering-Plough Corporation.

» more

© 2019 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy